Diphenidine: Difference between revisions
No edit summary |
(test and also change diphenidine dose to pull from factsheets) |
||
| (4 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
Diphenidine (1-(1,2-diphenylethyl)piperidine) is a dissociative anesthetic drug. | '''Diphenidine''' (1-(1,2-diphenylethyl)piperidine) is a dissociative anesthetic drug. | ||
== History == | == History == | ||
| Line 9: | Line 9: | ||
Shortly after the UK arylcyclohexylamine ban in early 2013, diphenidine and its 2-MeO derivative methoxphenidine emerged on the RC market. | Shortly after the UK arylcyclohexylamine ban in early 2013, diphenidine and its 2-MeO derivative methoxphenidine emerged on the RC market. | ||
= Dosage = | == Dosage == | ||
Diphenidine can also be insufflated, vaporized and injected. Start with low doses and work your way up. | Diphenidine can also be insufflated, vaporized and injected. Start with low doses and work your way up. | ||
{{#tdose: diphenidine }} | |||
== Duration == | |||
{| class="wikitable" | |||
|+ Oral | |||
|- | |||
| Onset || 15-30 minutes | |||
|- | |||
| Total || 2-5 hours | |||
|- | |||
| After-effects || 4-24 hours | |||
|} | |||
== Effects == | |||
=== Postive === | |||
= | |||
== | |||
* Stimulation | * Stimulation | ||
| Line 42: | Line 36: | ||
* Shifts in perception of reality | * Shifts in perception of reality | ||
== Neutral == | === Neutral === | ||
* Altered time perception | * Altered time perception | ||
| Line 49: | Line 43: | ||
* Confusion | * Confusion | ||
== Negative == | === Negative === | ||
* Severe dissociation, depersonalization | * Severe dissociation, depersonalization | ||
| Line 55: | Line 49: | ||
* Temporary amnesia | * Temporary amnesia | ||
= Harm Reduction = | == Harm Reduction == | ||
See [[Dissociatives#Harm_Reduction|Dissociative Harm Reduction]] for general information. | |||
=== Potentiators === | |||
== Potentiators == | |||
* CNS depressants | * CNS depressants | ||
== Interactions == | === Interactions === | ||
It is currently unknown whether diphenidine is a reuptake inhibitor of serotonin (SRI), if that is the case do '''NOT''' ever combine it with other SRIs (such as MXE) or SSRIs. | It is currently unknown whether diphenidine is a reuptake inhibitor of serotonin (SRI), if that is the case do '''NOT''' ever combine it with other SRIs (such as MXE) or SSRIs. | ||
| Line 73: | Line 63: | ||
Check out our [[Drug Combinations]] page and chart for interactions and combinations of common drugs. | Check out our [[Drug Combinations]] page and chart for interactions and combinations of common drugs. | ||
= Chemistry and Pharmacology = | == Chemistry and Pharmacology == | ||
Diphenidine is a NMDA antagonist and possibly a reuptake inhibitor of serotonin or dopamine. | Diphenidine is a NMDA antagonist and possibly a reuptake inhibitor of serotonin or dopamine. | ||
= Legal status= | == Legal status== | ||
Diphenidine is, as of July 2014, not a controlled substance in any country. | Diphenidine is, as of July 2014, not a controlled substance in any country. | ||
= Links = | == Links == | ||
[http://0-www.ncbi.nlm.nih.gov.elis.tmu.edu.tw/pubmed/24678061 From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.] | * [http://www.bluelight.org/vb/threads/668291-The-Big-amp-Dandy-Diphenidine-Thread Bluelight Big & Dandy thread] | ||
* [http://0-www.ncbi.nlm.nih.gov.elis.tmu.edu.tw/pubmed/24678061 From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.] | |||
[[Category:Dissociative]] | [[Category:Dissociative]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Research Chemical]] | |||
Latest revision as of 10:10, 7 May 2016
Diphenidine (1-(1,2-diphenylethyl)piperidine) is a dissociative anesthetic drug.
History
The first synthesis of diphenidine was published in 1924 by Christiaen who used a modified Brulyants reaction, similar to the reaction later used by Maddox in the first PCP synthesis.
While diphenidine was never used or investigated medically, several related compounds have been and include the withdrawn analgesic lefetamine and investigational compounds such as AstraZenica’s NMDA antagonist antidepressant Lanicemine, and neurodegenerative disease and anti-epileptic agent Remacemide.
Shortly after the UK arylcyclohexylamine ban in early 2013, diphenidine and its 2-MeO derivative methoxphenidine emerged on the RC market.
Dosage
Diphenidine can also be insufflated, vaporized and injected. Start with low doses and work your way up.
{{#tdose: diphenidine }}
Duration
| Onset | 15-30 minutes |
| Total | 2-5 hours |
| After-effects | 4-24 hours |
Effects
Postive
- Stimulation
- Euphoria
- Disconnected thoughts
- Shifts in perception of reality
Neutral
- Altered time perception
- Disrupted speech patterns
- Distorted sensory perceptions, hallucinations
- Confusion
Negative
- Severe dissociation, depersonalization
- Ataxia (loss of motor coordination)
- Temporary amnesia
Harm Reduction
See Dissociative Harm Reduction for general information.
Potentiators
- CNS depressants
Interactions
It is currently unknown whether diphenidine is a reuptake inhibitor of serotonin (SRI), if that is the case do NOT ever combine it with other SRIs (such as MXE) or SSRIs.
Check out our Drug Combinations page and chart for interactions and combinations of common drugs.
Chemistry and Pharmacology
Diphenidine is a NMDA antagonist and possibly a reuptake inhibitor of serotonin or dopamine.
Legal status
Diphenidine is, as of July 2014, not a controlled substance in any country.